Download PDF
Radiopraxis 2021; 14(01): E1-E14
DOI: 10.1055/a-1337-5521
CPD–Fortbildung

Konventionelle nuklearmedizinische Bildgebung bei Hyperparathyreoidismus

Simone Schenke
,
Michael Zimny
,
Michael C. Kreißl
› Further Information
Also available at
    Permissions and Reprints

Beim primären Hyperparathyreoidismus liegt in der Regel ursächlich ein solitäres Nebenschilddrüsenadenom vor. Die präoperative Lokalisationsdiagnostik ist hilfreich bei der Auswahl des geeigneten Operationsverfahrens. Für die konventionelle nuklearmedizinische Diagnostik einer Nebenschilddrüsenüberfunktion wird neben der Sonografie der Halsweichteile standardmäßig die Bildgebung mit 99 mTc-Sestamibi (MIBI) eingesetzt.



Publication History

Article published online:
10 March 2021

© 2021. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • Literatur

  • 1 Sheu-Grabellus S-Y, Schmid KW. Pathologie der Nebenschilddrüse. Pathologe 2015; 36: 229-236
    CrossrefPubMedGoogle Scholar
  • 2 Noda S, Onoda N, Kashiwagi S. et al. Strategy of operative treatment of hyperparathyroidism using US scan and (99 m) Tc-MIBI SPECT/CT. Endocr J 2014; 61: 225-230
    CrossrefPubMedGoogle Scholar
  • 3 Huppert BJ. Reading CC. Parathyroid sonography: imaging and intervention. – PubMed – NCBI. Im Internet (Stand: 23.07.2020): https://www.ncbi.nlm.nih.gov/pubmed/?term=Huppert+Parathyroid+sonography%3A+imaging+and+intervention
  • 4 Schlosser K, Wirowski D. Primärer Hyperparathyreoidismus – Teil 1: Epidemiologie, Anatomie und Symptomatik. Allg Viszeralchir Up2date 2013; 1: 23-26
    Google Scholar
  • 5 Kedarisetty S, Fundakowski C, Ramakrishnan K. et al. Clinical value of Tc99 m-MIBI SPECT/CT versus 4 D-CT or US in management of patients with hyperparathyroidism. Ear Nose Throat J 2019; 98: 149-157
    CrossrefPubMedGoogle Scholar
  • 6 Guilmette J, Sadow PM. Parathyroid pathology. Surg Pathol Clin 2019; 12: 1007-1019
    CrossrefPubMedGoogle Scholar
  • 7 Schlosser K, Wirowski D. Primärer Hyperparathyreoidismus – Teil 2: Diagnostisches und therapeutisches Vorgehen. Allg Viszeralchir Up2date 2013; 1: 39-56
    Google Scholar
  • 8 Zeng M, Liu W, Zha X. et al. 99 mTc-MIBI SPECT/CT imaging had high sensitivity in accurate localization of parathyroids before parathyroidectomy for patients with secondary hyperparathyroidism. Ren Fail 2019; 41: 885-892
    CrossrefPubMedGoogle Scholar
  • 9 Palestro CJ, Tomas MB, Tronco GG. Radionuclide imaging of the parathyroid glands. Semin Nucl Med 2005; 35: 266-276
    CrossrefPubMedGoogle Scholar
  • 10 Cheung K, Wang TS, Farrokhyar F. et al. A meta-analysis of preoperative localization techniques for patients with primary hyperparathyroidism. Ann Surg Oncol 2012; 19: 577-583
    CrossrefPubMedGoogle Scholar
  • 11 Rager O, Radojewski P, Dumont RA. et al. Radioisotope imaging for discriminating benign from malignant cytologically indeterminate thyroid nodules. Gland Surg 2019; 8: S118-S125
    CrossrefPubMedGoogle Scholar
  • 12 Arbab AS, Koizumi K, Toyama K. et al. Uptake of technetium-99 m-tetrofosmin, technetium-99 m-MIBI and thallium-201 in tumor cell lines. J Nucl Med 1996; 37: 1551-1556
    PubMedGoogle Scholar
  • 13 Schmidt M, Schenke S. Update 2019 zur MIBI-Szintigrafie bei hypofunktionellen Schilddrüsenknoten. Nuklearmediziner 2019; 42: 174-182
    Article in Thieme ConnectGoogle Scholar
  • 14 Treglia G, Sadeghi R, Schalin-Jäntti C. et al. Detection rate of (99 m) Tc-MIBI single photon emission computed tomography (SPECT)/CT in preoperative planning for patients with primary hyperparathyroidism: A meta-analysis. Head Neck 2016; 38 : (Suppl. 01): E2159-2172
    CrossrefPubMedGoogle Scholar
  • 15 Taillefer R, Boucher Y, Potvin C. et al. Detection and localization of parathyroid adenomas in patients with hyperparathyroidism using a single radionuclide imaging procedure with technetium-99 m-sestamibi (double-phase study). J Nucl Med 1992; 33: 1801-1807
    PubMedGoogle Scholar
  • 16 Xue J, Liu Y. , ji T. Comparison between technetium-99 m methoxyisobutylisonitrile scintigraphy and ultrasound in the diagnosis of parathyroid adenoma and parathyroid hyperplasia. Nucl Med Commun 2018; 39: 1129-1137
    CrossrefPubMedGoogle Scholar
  • 17 Sharma J, Mazzaglia P, Milas M. et al. Radionuclide imaging for hyperparathyroidism (HPT): which is the best technetium-99 m sestamibi modality? Surgery. 2006; 140: 856-863 ; discussion 863-865
    PubMedGoogle Scholar
  • 18 Coakley AJ, Kettle AG, Wells CP. et al. 99Tcm sestamibi-a new agent for parathyroid imaging. Nucl Med Commun 1989; 10: 791-794
    CrossrefPubMedGoogle Scholar
  • 19 Bekanntmachung der aktualisierten diagnostischen Referenzwerte für nuklearmedizinische Untersuchungen. Bundesamt für Strahlenschutz; 2012: Im Internet (Stand: 23.07.2020): https://www.bfs.de/DE/themen/ion/anwendung-medizin/diagnostik/referenzwerte/referenzwerte_node.html
  • 20 Hindié E, Ugur O, Fuster D. et al. 2009 EANM parathyroid guidelines. Eur J Nucl Med Mol Imaging 2009; 36: 1201-1216
    CrossrefPubMedGoogle Scholar
  • 21 Wong KK, Fig LM, Gross MD. et al. Parathyroid adenoma localization with 99 mTc-sestamibi SPECT/CT: a meta-analysis. Nucl Med Commun 2015; 36: 363-375
    CrossrefPubMedGoogle Scholar
  • 22 Kushchayeva YS, Tella SH, Kushchayev SV. et al. Comparison of hyperparathyroidism types and utility of dual radiopharmaceutical acquisition with Tc99 m sestamibi and 123I for localization of rapid washout parathyroid adenomas. Osteoporos Int 2019; 30: 1051-1057
    CrossrefPubMedGoogle Scholar
  • 23 Maccora D, Rizzo V, Fortini D. et al. Parathyroid scintigraphy in primary hyperparathyroidism: comparison between double-phase and subtraction techniques and possible affecting factors. J Endocrinol Invest 2019; 42: 889-895
    CrossrefPubMedGoogle Scholar
  • 24 Mihai R, Simon D, Hellman P. Imaging for primary hyperparathyroidism-an evidence-based analysis. Langenbecks Arch Surg 2009; 394: 765-784
    CrossrefPubMedGoogle Scholar
  • 25 Mshelia DS, Hatutale AN, Mokgoro NP. et al. Correlation between serum calcium levels and dual-phase (99 m)Tcsestamibi parathyroid scintigraphy in primary hyperparathyroidism. Clin Physiol Funct Imaging 2012; 32: 19-24
    CrossrefPubMedGoogle Scholar
  • 26 Silov G, Ozdal A, Erdoğan Z. et al. The relationship between technetium-99 m-methoxyisobutyl isonitrile parathyroid scintigraphy and hormonal and biochemical markers in suspicion of primary hyperparathyroidism. Mol Imaging Radionucl Ther 2013; 22: 8-13
    CrossrefPubMedGoogle Scholar
  • 27 Jorna FH, Hollema H, Hendrikse HN. et al. P-gp and MRP1 expression in parathyroid tumors related to histology, weight and (99 m)Tc-sestamibi imaging results. Exp Clin Endocrinol Diabetes 2009; 117: 406-412
    Article in Thieme ConnectPubMedGoogle Scholar
  • 28 Cordes M, Dworak O, Papadopoulos T. et al. MIBI scintigraphy of parathyroid adenomas: correlation with biochemical and histological markers. Endocr Res 2018; 43: 141-148
    CrossrefPubMedGoogle Scholar
  • 29 Calva-Cerqueira D, Smith BJ, Hostetler ML. et al. Minimally invasive parathyroidectomy and preoperative MIBI scans: correlation of gland weight and preoperative PTH. J Am Coll Surg 2007; 205: S38-44
    CrossrefPubMedGoogle Scholar
  • 30 Hassler S, Ben-Sellem D, Hubele F. et al. Dual-isotope 99 mTc-MIBI/123I parathyroid scintigraphy in primary hyperparathyroidism: comparison of subtraction SPECT/CT and pinhole planar scan. Clin Nucl Med 2014; 39: 32-36
    CrossrefPubMedGoogle Scholar
  • 31 Gayed IW, Kim EE, Broussard WF. et al. The value of 99 mTcsestamibi SPECT/CT over conventional SPECT in the evaluation of parathyroid adenomas or hyperplasia. J Nucl Med 2005; 46: 248-252
    PubMedGoogle Scholar
  • 32 Neumann DR, Obuchowski NA, Difilippo FP. Preoperative 123I/99 mTc-sestamibi subtraction SPECT and SPECT/CT in primary hyperparathyroidism. J Nucl Med 2008; 49: 2012-2017
    CrossrefPubMedGoogle Scholar
  • 33 Ozderya A, Temizkan S, Gul AE. et al. Biochemical and pathologic factors affecting technetium-99 m-methoxyisobutylisonitrile imaging results in patients with primary hyperparathyroidism. Ann Nucl Med 2018; 32: 250-255
    CrossrefPubMedGoogle Scholar
  • 34 Aller SG, Yu J, Ward A. Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding. Science 2009; 232: 1718-1722
    CrossrefPubMedGoogle Scholar
  • 35 Yamaguchi S, Yachiku S, Hashimoto H. Relation between technetium 99 m-methoxyisobutylisonitrile accumulation and multidrug resistance protein in the parathyroid glands. Wold J Surg 2002; : 29-34
    CrossrefGoogle Scholar
  • 36 Kao A, Shiau Y-C, Tsai S-C. et al. Technetium-99 m methoxyisobutylisonitrile imaging for parathyroid adenoma: relationship to P-glycoprotein or multidrug resistancerelated protein expression. Eur J Nucl Med Mol Imaging 2002; 29: 1012-1015
    CrossrefPubMedGoogle Scholar
  • 37 Sun SS, Shiau YC, Lin CC. et al. Correlation between P-glycoprotein (P-gp) expression in parathyroid and Tc-99 m MIBI parathyroid image findings. Nucl Med Biol 2001; 28: 929-933
    CrossrefPubMedGoogle Scholar
  • 38 Ruda JM, Hollenbeak CS, Stack BC. A systematic review of the diagnosis and treatment of primary hyperparathyroidism from 1995 to 2003. Otolaryngol Head Neck Surg 2005; 132: 359-372
    CrossrefPubMedGoogle Scholar
  • 39 Caldarella C, Treglia G, Pontecorvi A. et al. Diagnostic performance of planar scintigraphy using 99 mTc-MIBI in patients with secondary hyperparathyroidism: a meta-analysis. Ann Nucl Med 2012; 26: 794-803
    CrossrefPubMedGoogle Scholar
  • 40 Nichols KJ, Tronco GG, Palestro CJ. Influence of multigland parathyroid disease on 99 mTc-Sestamibi SPECT/CT. Clin Nucl Med 2016; 41: 282-288
    CrossrefPubMedGoogle Scholar
  • 41 Takebayashi S, Hidai H, Chiba T. et al. Hyperfunctional parathyroid glands with 99 mTc-MIBI scan: semiquantitative analysis correlated with histologic findings. J Nucl Med 1999; 40: 1792-1797
    PubMedGoogle Scholar
  • 42 Erbil Y, Kapran Y, I?sever H. et al. The positive effect of adenoma weight and oxyphil cell content on preoperative localization with 99 mTc-sestamibi scanning for primary hyperparathyroidism. Am J Surg 2008; 195: 34-39
    CrossrefPubMedGoogle Scholar
  • 43 Elgazzar AH, Anim JT, Dannoon SF. et al. Ultrastructure of Hyperfunctioning Parathyroid Glands: Does it Explain Various Patterns of 99 mTc-sestamibi Uptake. World J Nucl Med 2017; 16: 145-149
    Article in Thieme ConnectPubMedGoogle Scholar
  • 44 Araz M, Çayir D, Erdoğan M. et al. Factors affecting the sensitivity of Tc-99 m methoxyisobutylisonitrile dual-phase parathyroid single photon emission computed tomography in primary hyperparathyroidism. Nucl Med Commun 2017; 38: 117-123
    CrossrefPubMedGoogle Scholar
  • 45 Friedman K, Somervell H, Patel P. et al. Effect of calcium channel blockers on the sensitivity of preoperative 99 mTc-MIBI SPECT for hyperparathyroidism. Surgery 2004; 136: 1199-1204
    CrossrefPubMedGoogle Scholar
  • 46 Odparlik A, Hering AH. Lokalisationsdiagnostik von Nebenschilddrüsenadenomen mittels PET/CT. Der Nuklearmediziner 2020; 43: 244-248
    Article in Thieme ConnectGoogle Scholar